학술논문
Beyond Osimertinib: The Development of Third-Generation EGFR Tyrosine Kinase Inhibitors For Advanced EGFR+ NSCLC
Document Type
Review Article
Author
Source
In Journal of Thoracic Oncology May 2021 16(5):740-763
Subject
Language
ISSN
1556-0864